Patients with internal oncological diseases (head and neck tumors, tumors of the gastrointestinal tract (including liver, gallbladder, pancreas) and lungs, urothelial carcinomas, renal cell carcinomas, prostate carcinomas, penile carcinomas, CUP)
Conditions
Interventions
Group 1: Cancer patients, who underwent inpatient treatment between 01/2019 and 12/2023 and received palliative complex therapy for the first time during this treatment.
Sponsors
ev. Kliniken Essen Mitte
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - internal oncological disease (tumors of the gastrointestinal tract (including liver, gallbladder, pancreas) and lungs, urothelial carcinoma, renal cell carcinoma, prostate or penis carcinoma, CUP) - received palliative complex therapy (8-982.x ) for the first time during an inpatient stay between 01.01.2019 and 31.12.2023
Exclusion criteria
Exclusion criteria: Patients, - whose palliative treatment was billed according to 8-98e or 8-98h - who had previously received palliative complex treatment at the ev. Kliniken Essen Mitte - with a haematological/senological/gynaecological tumor disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Data collection of patient characteristics, symptoms, need for professional groups, further care after discharge, time of first palliative complex therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences between the data of patients with various tumour entities and age groups | — |
Countries
Germany
Contacts
Public ContactCarolin Wilharm
ev. Kliniken Essen Mitte
Outcome results
None listed